Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1Adenocarcinoma 1

Interventions

pembrolizumab 553Specimen Handling 466Carboplatin 442Magnetic Resonance Spectroscopy 430Cyclophosphamide 415Cisplatin 397Radiotherapy 312Gemcitabine 309Bevacizumab 309Paclitaxel 295Biopsy 259Drug Therapy 249Capecitabine 242fludarabine 239Oxaliplatin 239Nivolumab 225venetoclax 219Injections 213Docetaxel 205Fluorouracil 203Dexamethasone 186Radiosurgery 172Rituximab 158Pemetrexed 153Standard of Care 147durvalumab 143Leucovorin 139atezolizumab 138toripalimab 134tislelizumab 134

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Interventional × Prodrugs × Clear all
NCT07332000 2026-03-20

A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec

Candel Therapeutics, Inc.

Phase 2 Recruiting
45 enrolled
Genitourinary

Adenocarcinoma, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡